Core Insights - Jiangsu Zhenyi Medical Technology Co., Ltd. has completed a C-round financing of several hundred million yuan, focusing on "blood flow management" in the high-end medical device sector [2][3] - The financing was led by multiple institutions including Dongfang Fuhai, Guoyuan Equity, and others, indicating strong investor interest in innovative medical solutions [2] Company Overview - Zhenyi Medical is recognized as an innovative high-end medical device company, focusing on high mortality and disability rate diseases that remain unaddressed in the domestic market [2] - The company has a comprehensive business coverage across four major disease areas: heart valve, heart failure, peripheral, and coronary artery diseases, making it the first domestic company to fully engage in these critical sectors [2] Innovation and Product Development - The company has applied for over 160 patents, with 80% being invention patents and more than 40 PCT international patents, showcasing its commitment to innovation [2] - Currently, over 15 projects are under research, with four key products—mitral valve repair, tricuspid valve repair, mitral valve replacement, and shockwave balloon—rapidly advancing through clinical registration [2] - These products have received widespread recognition from patients, clinical doctors, and industry peers, positioning Zhenyi Medical as a leader in the domestic market [2] Strategic Expansion Plans - The chairman of Zhenyi Medical emphasized the need for a nationwide base network to support the launch of multiple innovative products and accelerate product development [3] - The company plans to establish a high-end production cluster in the Yangtze River Delta, with a focus on R&D in Shanghai, and aims to create research and production centers in key regions [3] - Zhenyi Medical intends to leverage domestic clinical resources to build specialized education and operation centers, exploring new paths for international medical cooperation and advancing its global strategy [3]